Streetbeat News

Earnings

TVTX

Travere Therapeutics reported Q3 2024 earnings with a GAAP EPS of $(0.70), meeting analyst expectations. The company achieved sales of $62.90 million, surpassing the $59.70 million estimate and marking a 69.56% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:11 am

OWL

Blue Owl Capital reported Q3 2024 earnings per share of $0.20, meeting analyst expectations, and sales of $600.878 million, surpassing estimates by 6.64%. This marks a 25% increase in EPS and a 39.85% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:09 am

IQV

IQVIA has updated its 2024 adjusted EPS forecast to $11.10-$11.20, slightly narrowing its previous guidance of $11.10-$11.30 and falling just below the consensus estimate of $11.21.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:09 am

OBE

Obsidian Energy reported Q3 2024 earnings of C$1.58 per share, surpassing the analyst consensus estimate of C$1.06 by 49.06%. This marks a 32.77% increase from the previous year's earnings of C$1.19 per share.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:09 am

SIRI

SiriusXM has revised its 2024 revenue guidance to $8.675 billion, slightly below the previous estimate of $8.75 billion and the market estimate of $8.75 billion. The company maintained its guidance for adjusted EBITDA at $2.7 billion and free cash flow at $1 billion.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:09 am

XYL

Xylem has revised its 2024 financial outlook, now expecting revenue of $8.5 billion and adjusted EPS between $4.22 and $4.24. The company anticipates a 15% increase in reported revenue and a 5% increase on an organic basis, with an adjusted EBITDA margin of 20.5%.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:09 am

WEN

Wendy's Company has updated its FY24 adjusted EPS guidance to a range of $0.99-$1.01, aligning closely with the previous estimate of $0.99 and slightly narrowing from the prior view of $0.98-$1.02.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:08 am

CMCSA

Comcast shares rose as the company reported Q3 earnings and sales that exceeded analyst expectations.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:08 am

ANIK

Anika Therapeutics reported a Q3 2024 adjusted EPS of $(0.25), missing the consensus estimate of $(0.01) by a significant margin. Sales were $38.75M, also below the expected $42.08M, marking a 6.54% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:08 am

NVRI

Enviri has revised its fiscal year 2024 adjusted EPS outlook to a range of $(0.06) to $(0.16), down from the previous range of $0.07 to $(0.09), and below the estimated $0.03.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:07 am